- Home
- NTB vs CNTA Comparison
NTB vs CNTA Comparison
Compare NTB & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTB
- CNTA
- Stock Information
- Founded
- NTB 1858
- CNTA 2020
- Country
- NTB Bermuda
- CNTA United Kingdom
- Employees
- NTB N/A
- CNTA N/A
- Industry
- NTB Commercial Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- NTB Finance
- CNTA Health Care
- Exchange
- NTB Nasdaq
- CNTA Nasdaq
- Market Cap
- NTB 1.9B
- CNTA 1.6B
- IPO Year
- NTB 2016
- CNTA 2021
- Fundamental
- Price
- NTB $46.46
- CNTA $14.29
- Analyst Decision
- NTB Buy
- CNTA Strong Buy
- Analyst Count
- NTB 4
- CNTA 10
- Target Price
- NTB $49.25
- CNTA $28.78
- AVG Volume (30 Days)
- NTB 164.7K
- CNTA 992.4K
- Earning Date
- NTB 07-25-2025
- CNTA 08-12-2025
- Dividend Yield
- NTB 3.76%
- CNTA N/A
- EPS Growth
- NTB 7.68
- CNTA N/A
- EPS
- NTB 4.81
- CNTA N/A
- Revenue
- NTB $585,277,000.00
- CNTA $15,000,000.00
- Revenue This Year
- NTB $3.10
- CNTA N/A
- Revenue Next Year
- NTB $0.34
- CNTA N/A
- P/E Ratio
- NTB $9.61
- CNTA N/A
- Revenue Growth
- NTB 1.89
- CNTA 118.88
- 52 Week Low
- NTB $33.04
- CNTA $9.00
- 52 Week High
- NTB $46.89
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- NTB 69.93
- CNTA 61.38
- Support Level
- NTB $45.89
- CNTA $13.22
- Resistance Level
- NTB $46.89
- CNTA $14.74
- Average True Range (ATR)
- NTB 0.75
- CNTA 0.73
- MACD
- NTB 0.15
- CNTA 0.14
- Stochastic Oscillator
- NTB 90.57
- CNTA 85.11
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.